Five-year cost-utility analysis of acute renal replacement therapy: a societal perspective
- 813 Downloads
Assessment of the cost utility (CU) of acute renal replacement therapy (RRT) from a societal perspective during a 5-year follow-up.
This was a cross-sectional cohort study in a medical-surgical intensive care unit and an acute RRT unit of 410 consecutive patients treated with acute RRT in Helsinki University Hospital in 2000–2002. Five-year survival and health-related quality of life (HRQoL) were assessed and used to calculate quality-adjusted life years (QALYs) in two ways. They were first calculated for the 5-year follow-up period and, second, estimated for the expected lifetime. HRQoL was assessed by the EuroQol (EQ-5D) in 2003. The cost analysis included hospital costs during index hospitalization along with hospital and societal costs for the following 5 years. The CU ratio was determined as total costs divided by gained QALYs.
Median survival time for all patients was 0.20 years and the EQ-5D index score was 0.68, 0.18 lower than that of the age- and gender-matched general population. All RRT-treated patients gained 0.10 QALYs/patient and hospital survivors 2.54 QALYs in 5 years. Overall the CU ratio was poor [5 year median 271,116 (29,782–2,177,581) €/QALY]. However, it was acceptable (less than 50,000 €/QALY) in patients who survived for more than a year and did not need chronic RRT. Cost utility decreased with increasing age exceeding 1.0 million €/QALY in the older groups.
In general, the CU ratio of acute RRT is poor. However, it is acceptable in patients with renal recovery who survive for more than 1 year.
KeywordsCost-effectiveness Acute kidney injury Renal replacement therapy Quality of life Critical care Outcome
We thank Prof. Seppo Sarna for his help in the statistical analysis.
- 20.Johansen KL, Smith MW, Unruh ML, Siroka AM, O’Connor TZ, Palevsky PM, VA/NIH Acute Renal Failure Trial Network (2010) Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol 5:1366–1372PubMedCrossRefGoogle Scholar
- 23.Hamel MB, Phillips RS, Davis RB, Desbiens N, Connors AF, Teno JM, Wenger N, Lynn J, Wu AW, Fulkerson W, Tsevat J, for the SUPPORT Investigators, (1997) Outcomes and cost-effectiveness of initiating and continuing aggressive care in seriously ill hospitalized adults. Ann Intern Med 127:195–202PubMedGoogle Scholar
- 26.Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881PubMedCrossRefGoogle Scholar